Abstract
Acute pulmonary embolism (PE) spans a wide spectrum of clinical outcomes, with an overall mortality rate that exceeds 10% at 30 days.1 The most common cause of death within 30 days is right ventricular (RV) failure. Beyond 30 days, chronic underlying comorbidities such as cancer, congestive heart failure, or lung disease cause most PE deaths.1,2